Abstract
Introduction
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra and by the formation of Lewy bodies [1] . Additionally, PD is accompanied by neuronal oxidative stress injury [2] . The classic PD cell model generally uses 1-methyl-4-phenyl-pyridinium (MPP + ), rotenone, or 6-hydroxydopamine (6-OHDA) as neurotoxins that induce varying degrees of oxidative stress injury [3] . In the MPP + -induced PD cell model, MPP + can inactivate tyrosine hydroxylase in dopaminergic neurons and inhibit the oxidative stress injury of mitochondrial complex I [4] .
Statins inhibit 5-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, which plays a key role in the production of cholesterol. Furthermore, statins belong to a class of lipidlowering drugs widely used in the treatment of hyperlipidemia. Based on neurodegenerative disease research, different statins may have a beneficial effect in the treatment of dementia [5] , PD [6] , and Alzheimer's disease [7] .
Our previous study on simvastatin (Sim) therapy involving patients with PD confirmed that Sim is able to modulate NMDA receptors [8] and protect against dopaminergic neurodegeneration through the PI3K/Akt/caspase 3 pathway [9] . In a related study, we observed that the anti-oxidative stress function of Sim in dopaminergic neurons is very prominent. Previous evidence suggests that Sim is able to activate Nrf2 and respond positively to oxidative stress caused by H 2 O 2 [10] . We have determined the anti-oxidant properties of Sim. Moreover, we conducted an in-depth study to investigate its effects and the mechanism underlying the oxidative stress induced by MPP + in dopaminergic neuronal cells.
Materials and Methods
Cell culture and treatment SH-SY5Y cells, which were obtained from Sun Ye San University (Guangzhou, China), were grown in Dulbecco's modified Eagle's medium (DMEM; HyClone, Logan, UT) with 10% fetal bovine serum (Gibco, Gaithersburg, MD) and 1% penicillin-streptomycin.The experiment involving substantia nigra neurons was conducted as previously described [11] . Newborn C57BL/6J mice were obtained within 24 h of birth from HFK Bioscience Co., Ltd. (Beijing, China). Isolated neurons were cultured in DMEM containing F-12 and 1 mM glutamine. The SH-SY5Y cells and primary culture substantia nigra neurons were maintained at 37°C in an incubator containing 5% carbon dioxide. Sim was prepared with an ethanol-sodium hydroxide solution, stored at −20°C, and diluted to specific concentrations in the culture medium.
To produce oxidative stress, 100 mM MPP + (M7068, Sigma-Aldrich, St. Louis, MO) was freshly prepared in deionized water as a stock solution prior to each experiment. The SH-SY5Y cells and substantia nigra neurons were incubated with specific concentrations of Sim and MPP + (1 mM).
Glutathione assay
The glutathione (GSH) content was measured according to the manufacturer's recommendations for the glutathione assay kit (Solarbio). The GSH levels were quantified based on the absorbance at 412 nm, which was determined with a multimode plate reader.
Reactive oxygen species assay
Black 96-well plates were inoculated with cells. After a 24-h incubation, 10 μM 2′,7′-dichlorofluorescin diacetate was added. The cells were incubated at 37°C for 30 min and washed twice with DMEM before being treated with MPP + and Sim for 24 min. After 48 h, the absorbance at 488 nm was determined with a multimode plate reader.
Superoxide dismutase activity assay
The SH-SY5Y cells were treated with Sim or MPP + and were centrifuged at 12, 000 × g for 5 min at 4°C after cells were lysed. According to the manufacturer's instructions, the superoxide dismutase (SOD) level of the supernatant was measured based on the absorbance at 560 nm, which was determined with a multimode plate reader.
Quantitative polymerase chain reaction assay
Total RNA was extracted from the SH-SY5Y cells and substantia nigra neurons using the Trizol reagent as per the manufacturer's protocol. Total RNA (2 μg) was used as the template for a reverse transcription to cDNA with the HiFi-Script cDNA synthesis kit. The quantitative polymerase chain reaction (qPCR) assay was completed with the ABI 7500 system, SYBR Green I, and the following primers: Nrf2 forward primer (5′-TCTCGGATCACTCTCTGGCA-3′); reverse primer (5′-GTTACGAGGGGCCAACTCC-3′) HO-1 forward primer (5′-GGCCTCCCTGTACCACATCTA-3′); reverse primer (5′-GGAAGTAGACAGGGGCGAAGA-3′) NQO-1 forward primer (5′-TGCAGCGGCTTTGAAGAAG-3′); reverse primer (5′-AAGTTCGCAGGGTCCTTCAG-3′) GAPDH forward primer (5′-CTCCGGGTGATGCTTTTCCTA-3′); reverse primer (5′-AGTTGAGGTCAATGAAGGGGTC-3′) Each 20-μl qPCR solution comprised 2 μl target cDNA. The PCR program was as follows: 95°C for 5 min; 35 cycles at 95°C for 15 s, 65°C for 15 s, and 72°C for 30 s. Each reaction was repeated three times. For the negative control reaction, cDNA was replaced with an equal volume of ddH 2 O. The target gene expression levels were calculated according to the relative quantitative 2 −ΔΔCt method [11] .
Western blot assay
The SH-SY5Y cells were lysed and centrifuged, after which the protein in the supernatant was quantified using bicinchoninic acid. Nucleoproteins were extracted with the Nucleoprotein Extraction Kit (Sangon Biotech, Shanghai, China), following the manufacturer's instructions. Total protein (20 μg . The membranes were washed three times with TBST before an incubation in solutions with the corresponding secondary antibody (CWBio) to detect proteins. All experiments were conducted at least three times. Image J was used to detect the density of the visualized proteins relative to that of the loading control.
Immunofluorescence
The SH-SY5Y cells were seeded on lysine-treated circular slides in plates with 12 holes and immobilized with polyoxymethylene. The samples were blocked with 10% goat serum (Solarbio) and incubated in a 1% bovine serum albumin solution containing a primary antibody (1:200) against Nrf2. The samples were then incubated with the Alexa Fluor 555 (Thermo Fisher Scientific, Waltham, MA) secondary antibody (1:1000). Slides were sealed after adding DAPI and then observed with an LSM 780 confocal microscope (Zeiss, LSM 780).
Small interfering RNA silencing
The SH-SY5Y cells were treated with Nrf2 and ERK1/2 small interfering RNAs (siRNAs) (Santa Cruz Biotechnology, Dallas, TX) using 0.5μg lipofectamine 3000 as per the manufacturer's instructions.
Nicotinamide adenine dinucleotide phosphate oxidase activity assay
The activation of NADH oxidase (NOX) was analyzed in accordance with the instructions of the Micro NADH Oxidase (NOX) assay kit(BC0635, Solarbio, Beijing, China). The degree of NOX activation was based on the reduction of 2, 6-dichlorophenol indigo, which was measured with a spectrophotometer (600 nm wavelength). The NOX activity rate was recorded relative to that of the control group.
Statistical analysis
Data were expressed as the mean ± standard error of the mean. Comparisons between two groups were analyzed using an unpaired two-sided Student's t-test. Analysis of variance and Tukey's post hoc analysis were used to evaluate differences among the various treatments (SPSS version 17.0, SPSS Inc., Chicago, IL), with p < 0.05 considered statistically significant for all analyses. + were compared with that of the control group ( * p < 0.05 or *** p < 0.001, n = 5). We observed that there were no significant differences among the SH-SY5Y cells exposed to 0.1, 0.5, 1.0, 1.5, 2.5, or 5.0 μM Sim for 24 h (Fig. 1b) . However, greater cytotoxicity was observed for SH-SY5Y cells treated with a high dose (5 μM) of Sim over an extended period (72 h) than for the control cells ( Fig. 1c ) ( * p < 0.05 or *** p < 0.001, n = 5). The protective effect of Sim against MPP + (1 mM)-induced oxidative stress in SH-SY5Y cells and primary cultured substantia nigra neurons (PD model) was further investigated. As revealed in Fig. 1d , MPP + significantly decreased the viability of SH-SY5Y cells by 57.01 ± 2.60% ( *** p < 0.001, n = 5) and primary neurons by 47.14 ± 2.80% ( *** p < 0.001, n = 5) compared with the control levels. # p < 0.05, n = 5). MDA is a common marker of oxidative stress and oxygen toxicity because it is formed by the degradation of unsaturated lipids with ROS. The MDA content was significantly increased to 1.959 ± 0.14 nmol/mg in the MPP + -treated group, but was only 0.69 ± 0.09 nmol/mg in the control group (Fig. 2b ). After treatments with 1.0 and 1.5 μM Sim, the MDA level decreased significantly in cells exhibiting MPP + -induced oxidative stress to 1.474 ± 0.19 nmol/mg ( # p < 0.05 n = 5) and 1.284 ± 0.13 nmol/mg ( ## p < 0.01, n = 5), respectively. Additionally, GSH, which is an important anti-oxidant that can be reduced by NADPH reductase, is another indicator of intracellular oxidative stress. Important anti-oxidants, such as SOD, exist in almost all living cells requiring oxygen.
Results

Sim protects SH-SY5Y cells and primary neurons against MPP + -induced cytotoxicity
As shown in Fig. 2c and d, compared with the corresponding control group, the GSH and SOD levels in SH-SY5Y cells significantly decreased after a treatment with MPP + from 6.06 ± 0.45 μmol/mg to 2.87 ± 0.31 μmol/mg and 30.97 ± 2.57 U/mg to 11.76 ± 1.52 U/mg, 
Sim mediated its protective effect by increasing the expression of the anti-oxidant-encoding NRF2 in a dose-dependent manner
The anti-oxidant effect of Nrf2 is considered to be the most likely factor responsible for the intracellular regulation of reduction and oxidation reactions. We hypothesized that a Sim treatment can increase the expression of anti-oxidant-encoding genes, such as Nrf2, in SH-SY5Y cells. First, the relative expression levels of Nrf2, HO-1, and NQO-1 were measured by qPCR. The mRNA levels of Nrf2 (Fig. 3a ) ( * p < 0.05, ** p < 0.01, or *** p < 0.001, n = 5), HO-1 (Fig. 3b) ( *** p < 0.001, n = 5), and NQO-1 (Fig. 3c ) ( ** p < 0.01 or *** p < 0.001, n = 5) after a 24-h treatment with 0.1, 0.5, 1.0, and 5.0 μM Sim were significantly higher than the corresponding mRNA level in the control group, and were positively correlated with the Sim dose. Next, we observed the effect of Sim on Nrf2-related anti-oxidant system protein expression. The results showed that the Nrf2, HO-1, and NQO-1 levels ( * p < 0.05, ** p < 0. 01, or *** p < 0.001, n = 5) were significantly higher in the treated cells than in the control cells (Fig. 3d) . The relative values in Fig. 3e , f, and g increased to 240.20 ± 22.15%, 167.80 ± 20.77%, and 183.20 ± 17.03%, respectively. To confirm the effect of Sim on Nrf2 and determine whether it plays an important neuroprotective role, we analyzed Sim effects on the survival of the control and Nrf2-silenced SH-SY5Y cells exposed to MPP + . The nuclear Nrf2 levels in the control group and Sim treatment group are presented in Fig. 3h . After the addition of 1.5 μM Sim, the nuclear Nrf2 level significantly increased (Fig. 3i) ( *** p < 0.001, n = 5). Moreover, as indicated in Fig.  3j , Nrf2 appeared in the cytoplasm after the 1.5 μM Sim treatment. When Nrf2 expression was silenced, the protective effects of Sim appeared to be largely eliminated (Fig. 3k) (n = 5, p < 0.05 vs. MPP + + scrambled-siRNA). 
High Sim levels can increase cellular endogenous ROS levels by regulating ERK1/2
Previous studies revealed that mitogen-activated protein kinases, especially ERK, are important upstream regulators of Nrf2. Thus, we speculated that Sim activates the Nrf2 signaling pathway by regulating ERK1/2. As shown in Fig. 4a , the level of Phospho ERK1/2 in Sim-treated SH-SY5Y cells was significantly increased by 130.1 ± 6.45% ( ** p < 0.01, n = 5) compared with that of the control cells. The Nrf2-related anti-oxidant genes were then analyzed.
When SH-SY5Y cells were treated with 0.1, 0.5, or 1.0 μM Sim, no significant changes were observed in the MDA (Fig. 4b) , GSH (Fig. 4C) , and SOD (Fig. 4d) levels. However, the 1.5 μM Sim treatment induced significant changes in the MDA (Fig. 4b ) ( * p < 0.05, n = 5) and SOD ( Fig. 4d ) ( * p < 0.05, n = 5) levels. These results suggested that at high concentrations, Sim can increase intracellular ROS levels, which indicates the Sim-induced activation of Nrf2 is due to an increase in ERK1/2. 
ERK1/2 can significantly inhibit the Sim-induced upregulated expression of Nrf2-related anti-oxidant genes
To further verify the effect of Sim on Nrf2 expression via an ERK1/2-mediated mechanism, we investigated the effect of ERK1/2 siRNA on the activation of Nrf2 expression induced by Sim. After 1 and 1.5 μM Sim treatments of SH-SY5Y cells, the mRNA levels of Nrf2 (Fig. 5a), HO-1 (Fig. 5b) , and NQO-1 (Fig. 5c) were higher than the corresponding levels in the control group ( * p < 0.05, ** p < 0.01, or *** p < 0.001, n = 5). Comparable results were also observed in primary cultured dopaminergic neurons (Fig. 5d-f ) ( * p < 0.05, ** p < 0.01, or *** p < 0.001, n = 5). However, when SH-SY5Y cells were treated with ERK siRNA and Sim, the Sim-induced upregulated expression of Nrf2 (Fig. 5a) 
Sim inhibits NOX2 expression
Previous studies revealed that Sim can inhibit autophagy in muscle cells by inhibiting CYBB/NOX2. Therefore, we explored whether this mechanism is involved in the protective effect of Sim against MPP + -induced oxidative stress and cytotoxicity. Compared with the control group level, the NOX2 level (Fig. 6a ) ( ** p < 0.01, n = 5), and NOX activity ( (Fig. 6b) (n = 5), the abundance of NOX2 was significantly increased vs. the control group (Fig. 6a) ( # p < 0.05, n = 5).
Discussion
In this study, we analyzed for the first time the effects of Sim in a PD cell model. Sim is a lipid-lowering medication that works by decreasing cholesterol production by the liver. Furthermore, it is used in the treatment of hyperlipidemia and coronary heart disease and to upregulate the expression of genes related to the endogenous anti-oxidant system (Nrf2, HO-1, and NQO-1) in SH-SY5Y cells via an ERK1/2-mediated mechanism. With Sim, this mechanism can decrease the intracellular oxidative stress caused by MPP + in dopaminergic neuronal cells. The data from this study provide new insights into the neuroprotective mechanisms of Sim. Previous clinical studies revealed that Sim has the potential to decrease the risk of PD by lowering oxidative stress [12, 13] , and it can also affect the suppressive potential of pathological alpha-Syn by lowering cholesterol levels [14] . The fact that Sim can cross the blood-brain barrier as well as the considerable evidence supporting the beneficial effects of Sim on the central nervous system make Sim one of the more promising drugs for treating neurodegenerative diseases, including stroke [15, 16] and PD [17, 18] . Earlier investigations confirmed that ROS is produced during the maintenance of an essential metabolic balance in the body, as a series of anti-oxidant mechanisms stabilize the redox balance of cells [19, 20] . Homeostatic changes induce excessive ROS production, leading to DNA mutations and protein dysfunction that eventually result in damaged dopaminergic neurons and neuropathology. We used SH-SY5Y neurons, which have dopaminergic neuronal properties and are positive for tyrosine hydroxylase. We observed that Sim scavenges ROS, and a pre-incubation with Sim can significantly alleviate the oxidative stress of SH-SY5Y cells. Moreover, Sim is also beneficial because it protects dopaminergic neurons against PD lesions.
A series of studies concluded that Sim exhibits anti-oxidant activity [21] in different cells, including nerve cells. However, to our knowledge, the mechanism underlying the antioxidant system has not been elucidated. Our previous study indicated that Sim can regulate NMDA receptors and exhibit anti-anxiety and anti-inflammatory activities in a PD cell model [22] . In this study, we used a modeling approach different from that used in previous studies to evaluate the effect of Sim on MPP + -induced oxidative stress in PD models. Interestingly, in this study, we observed the protective effect of Sim against oxidative stress in neurons. Meanwhile, we determined that as the Sim dose increases, the level of ROS declines in the MPP + cell model, implying that Sim can trigger the resistance of nerve cells against MPP + oxidative stress. We further observed the effect of Sim on NOX2 production and activity in cells affected by MPP + -induced oxidative stress. Sim can inhibit NOX2 production in neurons with a dose range consistent with that reported in a previous study involving muscle cells [23] . Moreover, we observed NOX activity decreased after the Sim treatment, and was negatively correlated with Sim dose. Therefore, the effect of Sim on oxidative stress may be attributed to the inhibition of NOX activity.
Additionally, we observed that Sim had a direct effect on the removal of exogenous ROS. As previously demonstrated, Sim can activate Nrf2 in human melanoma cells and colon cancer cells [24] . Another study confirmed that Nrf2 is an important transcription factor involved in the anti-oxidant response [25] of cells, during which it binds to the anti-oxidant genes, HO-1 and NQO-1 [26] . Moreover, we found that Sim was able to upregulate ERK1/2 expression.
Furthermore, the activation of ROS/ERK/Nrf2 signaling pathways may improve the anti-oxidative stress and anti-inflammatory properties of Sim. Therefore, we believe that the results of this study highlight the Sim-induced decrease in the oxidative stress of MPP + PD model cells. Regarding the upregulated Nrf2, HO-1, and NQO-1 expression levels, we believe that statins, which are HMG-CoA reductase inhibitors, function by blocking hydroxymethyl acid metabolic pathways. Furthermore, the Sim-induced high Nrf2, HO-1, and NQO-1 expression levels decreased after ERK1/2 expression was silenced via ERK1/2 siRNA. Thus, we conclude that MPP + blocks the respiratory chain that causes elevated intracellular ROS levels. Sim increased ERK expression and activated the expression of Nrf2 and the associated anti-oxidant genes, thereby increasing resistance to oxidative stress.
It is noteworthy that in the cell anti-oxidant experiments, we only used the MPP + -induced PD cell model and did not observe other drug-induced oxidative stresses. However, Sim was able to increase ERK1/2 expression levels as well as the expression of Nrf2 and related anti-oxidant genes, which was necessary to verify our research in vivo. Our future research will lean toward the same direction, and we believe that other oxidative stress models will display comparable effects. We previously demonstrated that Sim can enhance the resistance to inflammation by regulating NMDA in a 6-OHDA PD mouse model. In this study, we revealed that Sim can regulate ERK in a cell model by activating Nrf2, which enhances the resistance to neuronal oxidative stress. Therefore, we believe that Sim is able to significantly decrease the onset of PD largely because of its anti-inflammatory effect against oxidative stress. However, further research is necessary to prove the protective effect of Sim on dopaminergic neurons.
Conclusion
In conclusion, this study shows that Sim regulates ERK1/2 expression and activates Nrf2 and associated anti-oxidant systems. Thus, Sim helps alleviate cardiovascular diseases by combating the oxidative stress caused by MPP + , and is expected to have a strong protective effect against neurodegenerative diseases.
